LENZ · NASDAQ · Biological Products, (No Diagnostic Substances)
Biological Products, (No Diagnostic Substances) company based in Solana Beach, Ca.
In the last 90 days, no insider of Lenz Therapeutics reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Revenue
$5.49M
+9.7% vs the same quarter a year earlier
Free cash flow, last 12 months
−$114M
This quarter −$38.7M, a year earlier −$11.7M
Net debt
—
Debt —, cash $24.2M, at Jun 30, 2026
Net income, last 12 months
−$126M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 11, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$19.1M
Year ended Dec 31, 2025
Net income, fiscal 2025
−$82.1M
A loss for the year
Shares outstanding
31.4M
As of Aug 5, 2026
Traded Mar 27 · filed 3 days later
The CEO of Lenz Therapeutics paid $251K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. The Lenz Therapeutics shares held grew by 57%.
Traded Mar 27 · filed 3 days later
The CFO of Lenz Therapeutics paid $64K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month. The Lenz Therapeutics shares held grew by 139%.
Traded Mar 27 · filed 3 days later
A Lenz Therapeutics director paid $50K out of pocket for Lenz Therapeutics shares. 2 other people at Lenz Therapeutics bought some too, in the same month.
Shawn Olsson (Chief Commercial Officer) sold ~$153K of Lenz Therapeutics
Scheduled in advanceShawn Olsson (Chief Commercial Officer) sold ~$108K of Lenz Therapeutics
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.